Log in to save to my catalogue

Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis

Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2398154712

Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis

About this item

Full title

Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis

Publisher

New York, USA: Cambridge University Press

Journal title

CNS spectrums, 2021-08, Vol.26 (4), p.338-344

Language

English

Formats

Publication information

Publisher

New York, USA: Cambridge University Press

More information

Scope and Contents

Contents

Prazosin has been an accepted treatment for patients with post-traumatic stress disorder (PTSD) who experience sleep disturbances, including nightmares. Results of a recent large randomized control trial did not find benefit of prazosin vs placebo in improving such outcomes. A meta-analysis that includes this most recent trial was conducted to exam...

Alternative Titles

Full title

Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2398154712

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2398154712

Other Identifiers

ISSN

1092-8529

E-ISSN

2165-6509

DOI

10.1017/S1092852920001121

How to access this item